Please assess the completion status of the following clinical trial:

Trial Title: A Novel Approach to Treating Androgenetic Alopecia in Females With Low Level Laser Therapy

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~Diagnosis of Androgenetic Alopecia / Female Pattern Hair Loss Fitzpatrick skin phototypes of I - IV Ludwig-Savin Hair Loss scale I - II In overall good health as determined by the physician investigator Active hair loss within the last 12 months Willingness to refrain from using all other hair growth products or treatments -~Exclusion Criteria:~Photosensitivity to the specific wavelength of light - 650 nanometers. Malignancy in the target treatment area Other forms of alopecia of the head Past medical history of a collagen-vascular disease, thyroid disease or other cutaneous or systemic disease that seriously affects the scalp.~In willingness to remove hair replacement products during the 16 weeks of therapy.~Using any medications deemed to inhibit hair growth as determined by the physician investigator.~-

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 60 Years
- Healthy Volunteers: t

Study Arms:
- Incandescent red light source (Type: PLACEBO_COMPARATOR): A red, incandescent light source replaces all laser output. The treatment sessions are self-administered at home, every other day, for 16 weeks.
- Handi-Dome Laser (Type: ACTIVE_COMPARATOR): Study subjects self-administer actual laser treatments, at home, every other day, for 16 weeks.

Based on this trial design, predict the completion outcome and termination type (if applicable).